Chugai's profit ahead of target in difficult first half
This article was originally published in Scrip
Executive Summary
Chugai's net profit in the first half to June 30th came in ¥3.4 billion ahead of the company's own forecast at ¥18.9 billion ($177.6 million), but still fell 10% short of last year's figure, hit by sharply lower sales of Tamiflu (oseltamivir).